Skip to main content
PLOS One logoLink to PLOS One
. 2008 Nov 19;3(11):10.1371/annotation/0f06471c-1993-4144-b785-d58924ac0b5c. doi: 10.1371/annotation/0f06471c-1993-4144-b785-d58924ac0b5c

Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

Jindong Chen, Kunihiko Futami, David Petillo, Jun Peng, Pengfei Wang, Jared Knol, Yan Li, Sok-Kean Khoo, Dan Huang, Chao-Nan Qian, Ping Zhao, Karl Dykema, Racheal Zhang, Brian Cao, Ximing J Yang, Kyle Furge, Bart O Williams, Bin Tean Teh
PMCID: PMC2585737

The published Figure 4 is an incorrect version, including too many panels. Please view the correct figure, containing only panels (A-D), here:

Figure 4. mTOR signaling pathway was activated in the cystic cells, cystic RCC cells.

Figure 4

(A) Cystic RCC was stained by hematoxylin and eosin (H&E). (B) No FLCN expression was detected in cystic RCC, indicating deletion of the BHD gene. Phosphorylated mTOR (C) and phosphorylated S6 (D) staining was observed in the corresponding FLCN-deficient cells. Scale bar = 50 µm.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES